Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Receivables - Net (2019 - 2025)

Historic Receivables - Net for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $13.8 million.

  • Pulmonx's Receivables - Net rose 1822.62% to $13.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.8 million, marking a year-over-year increase of 1822.62%. This contributed to the annual value of $13.1 million for FY2024, which is 838.5% up from last year.
  • As of Q3 2025, Pulmonx's Receivables - Net stood at $13.8 million, which was up 1822.62% from $15.9 million recorded in Q2 2025.
  • Pulmonx's Receivables - Net's 5-year high stood at $15.9 million during Q2 2025, with a 5-year trough of $5.1 million in Q1 2021.
  • In the last 5 years, Pulmonx's Receivables - Net had a median value of $8.9 million in 2023 and averaged $9.7 million.
  • In the last 5 years, Pulmonx's Receivables - Net soared by 5520.34% in 2021 and then soared by 436.48% in 2022.
  • Pulmonx's Receivables - Net (Quarter) stood at $6.6 million in 2021, then skyrocketed by 32.23% to $8.7 million in 2022, then surged by 39.51% to $12.1 million in 2023, then increased by 8.38% to $13.1 million in 2024, then rose by 5.16% to $13.8 million in 2025.
  • Its last three reported values are $13.8 million in Q3 2025, $15.9 million for Q2 2025, and $14.0 million during Q1 2025.